10 . 06 .2020
Press release
Galderma global research reveals struggles of people with rosacea and psoriasis of the face experiencing a lack of control and impact on mental wellbeing
12 . 05 .2020
Press release
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
06 . 05 .2020
Press release
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
01 . 05 .2020
Press release
CETAPHIL by Galderma unites forces to focus on hand health and safety with their "In Good Hands" initiative to fight COVID-19
22 . 04 .2020
Press release
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China
15 . 04 .2020
Press release
Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*
20 . 02 .2020
Press release
Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis
20 . 12 .2019
Press release
Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years
09 . 12 .2019
Press release
Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis